Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.
Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effect Marks final study needed for the upcoming FDA meeting for...
GLEN ALLEN, Va., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
GLEN ALLEN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -4.54545454545 | 1.1 | 1.28 | 0.9924 | 524175 | 1.10836281 | CS |
| 4 | -0.05 | -4.54545454545 | 1.1 | 1.28 | 0.9696 | 200805 | 1.08378746 | CS |
| 12 | 0.08 | 8.24742268041 | 0.97 | 1.28 | 0.9355 | 145532 | 1.06105863 | CS |
| 26 | -0.43 | -29.0540540541 | 1.48 | 3 | 0.9 | 1470195 | 1.28192406 | CS |
| 52 | -1.07 | -50.4716981132 | 2.12 | 4.12 | 0.765 | 2383521 | 1.97512939 | CS |
| 156 | -73.95 | -98.6 | 75 | 78.5 | 0.765 | 1178483 | 6.21191391 | CS |
| 260 | -38.95 | -97.375 | 40 | 127 | 0.765 | 1020525 | 23.963201 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
